European Environmentally Related Tax Revenue from Taxes on Transport in Manufacturing of Basic Pharmaceutical Products and Pharmaceutical Preparations by Country

In 2023, Germany led with the highest environmentally related tax revenue from transport in pharmaceutical manufacturing at 9.51 million USD, despite a slight decline of 0.92% from the previous year. Switzerland and Belgium followed, with varying performance; Belgium experienced growth, while Switzerland saw a decline. Notably, Austria's revenue increased, and Norway saw the most significant surge with a remarkable 11.26% rise. In contrast, countries like Portugal, Cyprus, and Romania faced substantial decreases, with Portugal experiencing a significant fall of 27.46%. Overall, year-on-year data shows notable geographical disparities in performance.

Future trends to watch in the European environmentally related tax revenue from transport in pharmaceutical manufacturing include:

• Germany and Austria maintaining their trend of robust performance.
• The potential stabilization or recovery in countries such as Ireland and Portugal, which previously saw steep declines.
• Consistent growth in Norway continuing to outpace other European nations.
• Monitoring the impacts of policy changes and environmental initiatives on tax revenues across emerging and smaller markets like Latvia and Croatia.